Skip to main content
. 2018 Nov 16;13:2367–2374. doi: 10.2147/CIA.S186199

Table 1.

Baseline characteristics of study subjects

Parameter Calcitriol-treatment (mean±SD) Placebo (mean±SD) P-value

Age, years 58.2±8.1 57.1±8.2 0.65
Height, m 154.6±5.2 156.2±6.1 0.27
Weight, kg 64.5±6.2 66.4±7.8 0.07
BMI, kg/m2 24.3±3.1 23.5±3.2 0.52
BMD, g/cm2 (L1–4) 0.788±0.10 0.813±0.28 0.66
BMD, g/cm2 (FN) 0.636±0.08 0.645±0.13 0.64
BMD, g/cm2 (total hip) 0.786±0.10 0.719±0.10 0.49
ASMI, kg/m2 6.18±0.73 5.95±0.69 0.07
FGF-23, pg/mL 101.7±46.0 120.55±52.6 0.31
SOST, pg/mL 103.4±28.0 118.79±24.7 0.29
PTH, pg/mL 44.78±15.5 47.0±21.1 0.08
25(OH)2D, ng/mL 17.10±7.8 15.8±9.6 0.22
CTX, pg/mL 416.2±125.8 393.26±132.1 0.47
BGP, ng/mL 18.7±4.8 20.3±7.1 0.30
ALP, IU/L 82.9±20.7 78.6±22.9 0.32
Blood glucose, mmol/L 6.02±1.0 5.8±1.2 0.29
UA, mmol/L 291.3±56.4 314.5±76.3 0.19
TC, mmol/L 5.6±0.8 5.2±0.9 0.054
TG, mmol/L 1.5±0.6 2.3±1.7 0.066
Serum Ca, mmol/L 2.44±0.08 2.37±0.19 0.32
Serum P, mmol/L 1.30±0.13 1.18±0.17 0.28
Urinary Ca, mmol 4.32±1.8 4.58±2.3 0.15
Serum Cr, mmol/L 60.3±9.3 64.5±11.6 0.61
GFR, mL/kg⋅s 110.2±23.5 115±22.7 0.53
Grip (left), kg 19.95 (17.75–22.0) 19.57 (17.0–22.0) 0.31
Grip (right), kg 21.70 (18.0–25.0) 21.86 (18.0–25.25) 0.66

Note: Data are presented as mean±SD or median (25th–75th percentile).

Abbreviations: 25(OH)2D, serum 1,25-dihydroxyvitamin D; ASMI, appendicular skeletal mass index; BGP, bone Gla protein or osteocalcin; BMD, bone mineral density; BMD (L1–4), BMD of lumbar vertebrae 1–4; BMD (FN), BMD of femur neck; BMD (total hip), BMD of total hip; BMI, body mass index; Cr, creatinine; CTX, cross-linked C-terminal telopeptide of type I collagen; FGF-23, fibroblast growth factor-23; GFR, glomerular filtration rate; Grip (left), grip strength of left hand; Grip (right), grip strength of right hand; PTH, parathyroid hormone; SOST, sclerostin; TC, total cholesterol; TG, triglyceride; UA, uric acid; Urinary Ca, 24-hour urinary calcium.